Search results
New 'trauma-informed' YWCA Regina building nearly complete, but $4.5M still needed
CBC via Yahoo News· 5 days ago...construction and the YWCA employees inside it were bright and sunny Tuesday morning, as they took...
“Captain America: Brave New World ”Trailer: Anthony Mackie and Harrison Ford Team Up for Marvel's...
People via Yahoo News· 2 days agoMarvel Studios unveiled the thrilling first teaser for Captain America: Brave New World on Friday,...
United Therapeutics (UTHR) Completes Enrolment in IPF Study
Zacks via Yahoo News· 3 days agoUnited Therapeutics UTHR announced full enrolment in the phase III TETON 2 study evaluating a...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo News· 6 days agoKisunla’s BLA was based on data from the TRAILBLAZER-ALZ 2 phase III study. According to Lilly,...
Company News for July 9, 2024
Zacks via Yahoo News· 5 days agoIDEAYA Biosciences, Inc. (IDYA) shares gained 15.3% after the precision medicine oncology company announced positive results from the phase 2 trial of...
Multi-million-dollar settlement talks prove LRT secrecy still a concern
CBC via Yahoo News· 5 days agoOttawa's latest light rail transit legal woes are highlighting an issue that's been a concern since...
Hugh Grant ‘miserable’ as he blames ‘scrolling’ and streaming for local cinema closure
The Independent via Yahoo News· 4 days agoWhile a third wrote: “Love this move for Hugh, he’s always had a great dark side but doesn’t always...
Euro 2024 final: Will the years of despair deepen England's determination?
Sky News via Yahoo News· 6 hours agoCan they finally add silverware by beating Spain tonight to join the Lionesses as European...
Some Massachusetts towns are trying to say goodbye to tobacco — forever
Washington Post via Yahoo News· 4 days agoBROOKLINE, Mass. - The idea was ingenious, Richard Lopez thought: a slow but relentless way to phase...
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Zacks via Yahoo News· 3 days agoIn June 2024, BEAM dosed the first patient in the phase I/II study to evaluate BEAM-302 for the...
